Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Saint-Cyr-Sur-Loire

17 clinical trials in Saint-Cyr-Sur-Loire, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Saint-Cyr-Sur-Loire at a glance
17
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

17 trials in Saint-Cyr-Sur-Loire

Open in trial search

A Phase 2/3 Study of intravitreal mk-8748 versus aflibercept in adults with neovascular age‑related macular degeneration

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Eyebiotech Limited

FWY003 in Geographic Atrophy Secondary to Age-Related Macular Degeneration in Patients

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:Novartis Pharma AG

Study of Faricimab Treatment Given Every 24 Weeks in Patients with Age-Related Macular Degeneration

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Faricimab
  • Sponsor:F. Hoffmann-La Roche AG

Study on the Effectiveness and Safety of GAL-101 Eye Drops for Patients with Geographic Atrophy from Age-Related Macular Degeneration

Investigational
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:SODIUM (R)-2-(2-AMINO-3-(1H-INDOL-3- YL)PROPANAMIDO)-2-METHYLPROPANOATE-PROPAN-2-OL
  • Sponsor:Galimedix Therapeutics Inc.

Study of dimethyl fumarate to slow the progression of geographic atrophy in patients with age-related macular degeneration (dry form)

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dimethyl Fumarate
  • Sponsor:Assistance Publique Hopitaux De Paris

A Phase 2 Study of Aganirsen Eye Drops to Extend Intravitreal Aflibercept Injection Interval in Patients with Wet Age‑Related Macular Degeneration

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Methylprednisolone
  • Sponsor:Assistance Publique Hopitaux De Paris

Coronary artery bypass

Not yet recruiting

Study of Levosimendan Before Tricuspid Valve Surgery in Patients with Right Ventricular Dysfunction

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Levosimendan
  • Sponsor:Assistance Publique Hopitaux De Paris

Faricimab for Choroidal Neovascularization Secondary to Pathologic Myopia in Patients with Pathologic Myopia

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Faricimab
  • Sponsor:F. Hoffmann-La Roche AG

Study on the Effectiveness and Safety of EYE103 Compared to Ranibizumab for Patients with Diabetic Macular Edema

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:EYE103
  • Sponsor:Eyebiotech Limited

Depression

Not recruiting

Study on Brain Inflammation in Patients with Major Depressive Disorder Using 18F-DPA-714

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · Healthy volunteers
  • Substances:N,N-DIETHYL-(2-(4-(2-(18F)FLUOROETHOXY)PHENYL)-5,7-DIMETHYLPYRAZOLO(1,5-A)PYRIMIDINE-3-YL)ACETAMIDE
  • Sponsor:Centre Hospitalier Universitaire De Toulouse

Prostate cancer

Not recruiting

Study on Hormonal Treatment with Leuprorelin Acetate for Prostate Cancer Patients at High Risk of Recurrence After Surgery

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Leuprorelin Acetate
  • Sponsor:Unicancer

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Saint-Cyr-Sur-Loire

What the registry says about research in the country

01 Mental Health Research

Studies focusing on neuroinflammation patterns in patients with major depressive disorder, comparing active cases against those in remission. This research aims to better understand the biological mechanisms underlying depression.

  • Depression biomarkers
  • Brain inflammation patterns
  • Comparative neurological studies

Innovative research using advanced imaging techniques to map brain inflammation responses.

02 Cardiovascular Studies

Investigation of treatment approaches for acute myocarditis, examining the effectiveness of corticosteroid therapy in patients with left-ventricular dysfunction.

  • Heart function assessment
  • Cardiac imaging
  • Treatment optimization

Evaluating novel therapeutic strategies for improved cardiac outcomes.

03 Ophthalmology Research

Multiple studies investigating treatments for geographic atrophy and macular degeneration, including novel therapeutics and long-term safety assessments.

  • AMD treatments
  • Vision preservation
  • Diabetic eye disease

Comprehensive research into sight-preserving interventions and therapies.

04 Oncology Studies

Research evaluating adjuvant hormonal treatment for high-risk prostate cancer patients following radical prostatectomy, focusing on long-term outcomes.

  • Prostate cancer treatment
  • Recurrence prevention
  • Post-surgical care

Advanced studies aimed at improving cancer survival rates.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.